Agenus stock doubles as biotech narrows Phase 3 bet
Agenus shares surged after the biotech secured upfront financing and shifted focus to a colon-cancer trial.
Read the full story at TST (Full) - (Official Feed) →
Agenus shares surged after the biotech secured upfront financing and shifted focus to a colon-cancer trial.
Read the full story at TST (Full) - (Official Feed) →